Trial finds adding abciximab to stent reperfusion improves survival in acute myocardial infarction
Publication
, Journal Article
Antoniucci, D; Rodriguez, A; Hempel, A; Tcheng, JE
Published in: Evidence Based Cardiovascular Medicine
January 1, 2004
Duke Scholars
Published In
Evidence Based Cardiovascular Medicine
DOI
ISSN
1361-2611
Publication Date
January 1, 2004
Volume
8
Issue
2
Start / End Page
147 / 148
Related Subject Headings
- Cardiovascular System & Hematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Antoniucci, D., Rodriguez, A., Hempel, A., & Tcheng, J. E. (2004). Trial finds adding abciximab to stent reperfusion improves survival in acute myocardial infarction. Evidence Based Cardiovascular Medicine, 8(2), 147–148. https://doi.org/10.1016/j.ebcm.2004.03.018
Antoniucci, D., A. Rodriguez, A. Hempel, and J. E. Tcheng. “Trial finds adding abciximab to stent reperfusion improves survival in acute myocardial infarction.” Evidence Based Cardiovascular Medicine 8, no. 2 (January 1, 2004): 147–48. https://doi.org/10.1016/j.ebcm.2004.03.018.
Antoniucci D, Rodriguez A, Hempel A, Tcheng JE. Trial finds adding abciximab to stent reperfusion improves survival in acute myocardial infarction. Evidence Based Cardiovascular Medicine. 2004 Jan 1;8(2):147–8.
Antoniucci, D., et al. “Trial finds adding abciximab to stent reperfusion improves survival in acute myocardial infarction.” Evidence Based Cardiovascular Medicine, vol. 8, no. 2, Jan. 2004, pp. 147–48. Scopus, doi:10.1016/j.ebcm.2004.03.018.
Antoniucci D, Rodriguez A, Hempel A, Tcheng JE. Trial finds adding abciximab to stent reperfusion improves survival in acute myocardial infarction. Evidence Based Cardiovascular Medicine. 2004 Jan 1;8(2):147–148.
Published In
Evidence Based Cardiovascular Medicine
DOI
ISSN
1361-2611
Publication Date
January 1, 2004
Volume
8
Issue
2
Start / End Page
147 / 148
Related Subject Headings
- Cardiovascular System & Hematology